BioWorld MedTech

Dec. 16, 2013

BioVentrix expands European trial of Revivent-TC via LIVE procedure

An implant intended to address the cause of heart failure that was once implanted during an open-chest procedure in the operating room is now being delivered via a less invasive technique in the catheter lab in a European clinical trial. Read More

Mindray moves upmarket with Zonare acquisition

International report: Echo grants rights to MTIA for Symphony CGM in China

Washington Roundup: Budget bill offers language for medical device tax repeal

Sundance will expand psychiatric evaluation

Grants: Ixico wins grant competition in UK for dementia products

Financings roundup: Xoma to sell common stock in public offering

Med-Tech Notes

People in Places

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...